Early diagnosis of Alzheimer's disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts

PM Rossini, R Di Iorio, F Vecchio, M Anfossi… - Clinical …, 2020 - Elsevier
Alzheimer's disease (AD) is the most common neurodegenerative disease among the
elderly with a progressive decline in cognitive function significantly affecting quality of life …

Diagnosis of Alzheimer's disease from EEG signals: where are we standing?

J Dauwels, F Vialatte, A Cichocki - Current Alzheimer Research, 2010 - benthamdirect.com
This paper reviews recent progress in the diagnosis of Alzheimer's disease (AD) from
electroencephalograms (EEG). Three major effects of AD on EEG have been observed …

Neurometabolic changes in the acute phase after sports concussions correlate with symptom severity

LC Henry, S Tremblay, Y Boulanger… - Journal of …, 2010 - liebertpub.com
Sports concussion is a major problem that affects thousands of people in North America
every year. Despite negative neuroimaging findings, many athletes display …

Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage

V Drago, C Babiloni, D Bartrés-Faz… - Journal of …, 2011 - journals.sagepub.com
Older persons with Mild Cognitive Impairment (MCI) feature neurobiological Alzheimer's
Disease (AD) in 50% to 70% of the cases and develop dementia within the next 5 to 7 years …

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020

H Hampel, S Lista, SJ Teipel, F Garaci, R Nistico… - Biochemical …, 2014 - Elsevier
Recent advances in understanding the molecular mechanisms underlying various paths
toward the pathogenesis of Alzheimer's disease (AD) has begun to provide new insight for …

Auditory system dysfunction in Alzheimer disease and its prodromal states: A review

GM Swords, LT Nguyen, RA Mudar, DA Llano - Ageing research reviews, 2018 - Elsevier
Recent findings suggest that both peripheral and central auditory system dysfunction occur
in the prodromal stages of Alzheimer Disease (AD), and therefore may represent early …

Biomarkers in Alzheimer's disease drug development

JL Cummings - Alzheimer's & Dementia, 2011 - Elsevier
Develo** new therapies for Alzheimer's disease (AD) is critically important to avoid the
impending public health disaster imposed by this common disorder. Means must be found to …

Cognitive event-related potentials: biomarkers of synaptic dysfunction across the stages of Alzheimer's disease

JM Olichney, JC Yang, J Taylor… - Journal of Alzheimer's …, 2011 - content.iospress.com
Cognitive event-related brain potential (ERP) studies of decision-making and attention,
language, and memory impairments in Alzheimer's disease (AD) and mild cognitive …

Tuning up the old brain with new tricks: attention training via neurofeedback

Y Jiang, R Abiri, X Zhao - Frontiers in aging neuroscience, 2017 - frontiersin.org
Neurofeedback (NF) is a form of biofeedback that uses real-time (RT) modulation of brain
activity to enhance brain function and behavioral performance. Recent advances in Brain …